Created by SHD coalition

Spanish Senate approves Motion on addressing structural heart diseases

After taking part in a virtual debate on the impact of COVID-19 and structural heart disease in the elderly, socialist Senator Esther Carmona proposed …

Created by SHD Coalition

Virtual debate with Spanish policymakers on the role of the heart

On 19 October the Spanish Confederation of Elderly Organisations (CEOMA) organised a virtual event with policymakers and experts to discuss the role of the heart …

Created by SHD Coalition


During a Roundtable held by the Galicia Sur Health Research Institute at the Álvaro Cunqueiro Hospital in Vigo, several experts discussed the current …

Estimated number of people with SHD in Spain

Percentages of population in Spain1

Key facts related to SHD in Spain

8,8 billion € of direct healthcare expenditure for cardiovascular diseases (CVD) in 20202.
CVD represented 8,31% of the total health public budget in 20153.
In 2040, 14% of people over 65 will have SHD, which represents 4,36% of the total population4.

Key messages

  • Spain is one of the fastest ageing countries in the world; soon 1 in 3 inhabitants will be over 65 years old. This will lead to an increase of the incidence of cardiovascular diseases.
  • Although valve disease affects gender equally, reality shows infradiagnosis within women.4
  • Heart Valve diseases account for 8% to 26% of heart failures5, which are the first cause of hospitalization of people over 65 years old in Spain6.
  • 59% of patients diagnosed with severe aortic stenosis do not receive intervention. 14% of intervened patients remain on waiting list after one year, and 19% of them die before getting any treatment7.
  • SHD is a major cause of functional decline in the elderly population and as such, Spanish policies must tackle SHD as part of ageing strategies.
  • Investments in health innovations for this population are an economic necessity for Spain to adapt to the new demographic challenges.
  • Hospitalisations due to structural heart diseases are on the rise, even though hospitalisations for cardiovascular diseases in general have been declining during the last decade8


  1. Instituto Nacional de Estadística (2016) Proyecciones de Población 2016-2066 [retrieved on: 25/July/2018]
  2. Centre for Economics and Business Research (2014) Coste económico de las enfermedades cardiovasculares desde 2014 a 2020 en seis países europeos [retrieved on: 25/July/2018]
  3. Ministerio de Sanidad, Servicios Sociales e Igualdad (2015) Diferentes series de gasto sanitario [retrieved on: 25/July/2018]
  4. Ferreira-González I et al. Prevalence of calcific aortic valve disease in the elderly and associated risk factors: a population-based study in a Mediterranean area.Eur J Prev Cardiol. 2013 Dec;20(6):1022-30. doi: 10.1177/2047487312451238. Epub 2012 Jun 7.0140673606692088
  5. Nkomo VT et al. Burden of valvular heart diseases: a population-based study. The Lancet. 2006 Sep;368(9540):1005-11. doi: 10.1016/S0140-6736(06)69208-8.
  6. I. Sayago-Silva et al. Epidemiología de la insuficiencia cardíaca en España en los últimos 20 años, Rev. Esp. Cardiol., 2013;66:649-56 - Vol. 66 Núm.08 doi: 10.1016/j.recesp.2013.03.014.
  7. González Saldivar H, et al. Prognosis of Patients With Severe Aortic Stenosis After the Decision to Perform an Intervention. Rev Esp Cardiol. 2018.
  8. Recent Trends in Hospitalizations for Cardiovascular Disease, Stroke, and Vascular Cognitive Impairment in Canada